Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvespimycin in Her2 Positive Breast Cancer
NCT00780000Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of alvespimycin in breast cancer, sponsored by Bristol Myers Squibb. Started Apr 2008; status: terminated.
02
Drugs
alvespimycin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00780000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00780000.